|
An artificial heart is an implanted prosthetic device that replaces the heart. As part of the artificial heart implantation, a substantial part of the biological heart is removed. Medicare provides coverage for artificial hearts under the Coverage with Evidence Development (CED) paradigm when the device is implanted as part of a CMS approved study. Detailed information regarding the CED criteria and CMS approval process are available in the National Coverage Determination. CMS will maintain a list of all approved studies and post that list on this webpage. Study Title: A post-approval study to monitor the clinical performance of the AbioCor in severe end-stage heart disease
Sponsor: Abiomed, Inc.
ClinicalTrials.gov Number: NCT00669357
CMS Approval Date: 5/14/08 Study Title: The SynCardia CardioWest TAH-t postmarket surveillance study Sponsor: SynCardia Systems, Inc. ClinicalTrial.gov Number: NCT00614510 CMS Approval Date: 5/14/08
Page Last Modified: 05/15/2008 11:17:33 AM
Help with File Formats and Plug-Ins
Submit Feedback
|
Email
Print